Injective and Kava Partner to Expand Access to Stable Assets and Boost DeFi

Injective, a leading Layer 1 for cross-chain assets, has announced a new partnership with Kava, a decentralized blockchain platform. This partnership will bring native USDt to Injective’s ecosystem and further fortify its position as a leading L1 chain for interoperability.

What Does This Partnership Entail?

The partnership will enable exchange dApps on Injective to add Kava and trade it seamlessly within the Injective network. This new listing will bring further diversity of assets into the Injective ecosystem, while still maintaining the fast speeds, zero gas fees, and market-leading rewards.

Exchange dApps built on Injective will also add perpetual markets with the USDt quote asset. USDTkv will be available immediately, allowing users to leverage, hedge and more with Kava’s USDt serving as the underlying asset.

Traders participating in Injective’s Open Liquidity Program will be able to earn rewards by actively trading on these two new perpetual markets with USDTkv. A total of 100,000 KAVA will be available as rewards per trading epoch.

Benefits of the Partnership

The partnership between Injective and Kava offers a number of benefits to both platforms and their users, including:

• Expanded access to stable assets: Injective users will now have access to native USDt on the Injective platform, which is a highly sought-after stable asset. This will make it easier and more convenient for Injective users to trade, invest, and participate in DeFi activities.
• Increased liquidity: The integration of Kava into Injective will bring additional liquidity to the Injective ecosystem, which will benefit users by providing them with tighter spreads and deeper order books.
• Reduced risk: By diversifying their asset exposure, Injective users can reduce their overall risk. The integration of Kava provides users with access to a new asset class, which can help them reduce their risk profile.
• New opportunities: The integration of Kava will open up new opportunities for Injective users. For example, users can trade new perpetual markets with the USDt quote asset. Users will also be able to earn rewards for participating in the Open Liquidity Program.
• Boost to DeFi: The partnership between Injective and Kava will boost DeFi by providing users with more choices, better liquidity, and lower fees. This will make DeFi more accessible and attractive to a wider range of users.

Conclusion

The partnership between Injective and Kava is a positive development for the DeFi ecosystem as a whole. It will expand access to stable assets, increase liquidity, reduce risk, and open up new opportunities for users.

About Kava

Kava is a decentralized blockchain that seeks to combine the speed and interoperability of Cosmos, with the developer power of Ethereum. Natively built with the Cosmos SDK, Kava is highly interoperable and boasts an EVM-compatible execution environment that empowers Solidity developers and their dApps to quickly deploy to its network.

About Injective

Injective is a lightning-fast interoperable layer one blockchain optimized for building the premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps.

Website | Telegram | Discord | Blog | Twitter | Learn | Youtube | Facebook|LinkedIn | Reddit | Instagram |Orbit Newsletter